res m glp-1 resbiotic Unveils resM™ Postbiotic--A Groundbreaking Innovation in Gut & Metabolic Health Resbiotic Expands Global Footprint with

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

Michelle and Leslie were helping me and they were great

A Converging Model of Brain Resilience Building on these mechanisms, a unifying model begins to emerge: estrogen and GLP-1 signaling converge on shared processes that govern neuronal energy balance, inflammatory tone, and cellular survival

[1] Failure to treat this disorder causes psychological damage and many social and economic complications for patients

Eli Lillys once-weekly injectable retatrutide dubbed triple G because it mimics three hormones is expected to seek FDA approval this year, with early data suggesting it could deliver an even bigger weight-loss punch than earlier GLP-1s